Mer­ck notch­es 38th ap­proval for Keytru­da, sev­enth in­di­ca­tion for gas­troin­testi­nal can­cer

The FDA on Thurs­day ap­proved Mer­ck’s an­ti-PD-1 ther­a­py to treat a type of gas­troin­testi­nal can­cer in com­bi­na­tion with chemother­a­py, mark­ing the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA